Login / Signup

Azithromycin for bacterial watery diarrhea: A reanalysis of the AntiBiotics for Children with severe Diarrhea (ABCD) trial incorporating molecular diagnostics.

Patricia B PavlinacJames Platts-MillsJie LiuHannah E AtlasJean GratzDarwin OperarioElizabeth Rogawski McQuadeDilruba AhmedTahmeed AhmedTahmina AlamPer AshornHenry BadjiRajiv BahlNaor Bar-ZeevMohammod Jobayer ChistiJen CornickAishwarya ChauhanAyesha De CostaSaikat DebUsha DhingraQueen DubeChristopher P DugganBridget FreyneWilson GumbiAneeta HotwaniMamun KabirOhedul IslamFurqan KabirIrene KasumbaUpendo KibwanaKaren L KotloffShaila S KhanVictor MaidenKarim ManjiAshka MehtaLatif NdeketaIra PraharajFarah Naz QamarSunil SazawalJonathon SimonBenson O SingaSarah SomjiSamba O SowMilagritos D TapiaCaroline TigoiAliou ToureJudd L WalsonMohammad Tahir YousafzaiEric R Houptnull null
Published in: The Journal of infectious diseases (2023)
Acute watery diarrhea confirmed or presumed to be of bacterial etiology may benefit from azithromycin treatment.
Keyphrases
  • irritable bowel syndrome
  • clostridium difficile
  • liver failure
  • young adults
  • study protocol
  • clinical trial
  • phase iii
  • early onset
  • randomized controlled trial
  • phase ii
  • combination therapy
  • open label